Abacus Life Q1 EPS Forecast Increased by Northland Capmk

Abacus Life, Inc. (NASDAQ:ABL) – Investment analysts at Northland Capmk boosted their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a research report issued on Friday, March 28th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings of $0.18 per share for the quarter, up from their prior forecast of $0.15. The consensus estimate for Abacus Life’s current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life’s Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.23 EPS, Q4 2025 earnings at $0.27 EPS and FY2025 earnings at $0.88 EPS.

Separately, B. Riley lowered their price objective on shares of Abacus Life from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Abacus Life currently has a consensus rating of “Buy” and an average target price of $14.30.

Abacus Life Price Performance

Shares of Abacus Life stock opened at $7.33 on Monday. The firm has a market cap of $708.41 million, a PE ratio of -40.72 and a beta of 0.14. Abacus Life has a 12-month low of $6.75 and a 12-month high of $12.50. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. The company’s fifty day simple moving average is $7.61 and its two-hundred day simple moving average is $8.24.

Abacus Life (NASDAQ:ABL) last released its quarterly earnings data on Thursday, March 27th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The firm had revenue of $33.21 million during the quarter, compared to analyst estimates of $28.76 million.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Richard W. Paul & Associates LLC boosted its stake in shares of Abacus Life by 7.5% during the 4th quarter. Richard W. Paul & Associates LLC now owns 41,836 shares of the company’s stock valued at $328,000 after purchasing an additional 2,934 shares in the last quarter. Bank of America Corp DE lifted its holdings in Abacus Life by 2.6% in the fourth quarter. Bank of America Corp DE now owns 161,458 shares of the company’s stock worth $1,264,000 after buying an additional 4,162 shares during the period. Geode Capital Management LLC boosted its position in Abacus Life by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 177,227 shares of the company’s stock valued at $1,389,000 after acquiring an additional 5,310 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Abacus Life by 31.0% during the 4th quarter. LPL Financial LLC now owns 23,288 shares of the company’s stock worth $182,000 after acquiring an additional 5,507 shares during the period. Finally, Point72 Asset Management L.P. raised its position in shares of Abacus Life by 2.5% in the 4th quarter. Point72 Asset Management L.P. now owns 323,432 shares of the company’s stock worth $2,532,000 after acquiring an additional 7,838 shares in the last quarter.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.